Chimerix, Inc. Profile Avatar - Palmy Investing

Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is …

Biotechnology
US, Durham [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CMRX's Analysis
CIK: 1117480 CUSIP: 16934W106 ISIN: US16934W1062 LEI: - UEI: -
Secondary Listings
CMRX has no secondary listings inside our databases.